DIAMONDTEMP¿
Report
- Report Number
- 3015180993-2025-00010
- Event Type
- Injury
- Date Received
- December 17, 2025
- Date of Event
- October 8, 2025
- Report Date
- December 17, 2025
- Manufacturer
- EPIX THERAPEUTICS
- Product Code
- OAE
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
IT WAS REPORTED THAT DURING A PULMONARY VEIN ISOLATION ABLATION IT WAS OBSERVED THAT THE CATHETER PERFORATED THE SURFACE OF THE LEFT ATRIUM. A PERICARDIAL EFFUSION OCCURRED, CONFIRMED WITH AN ECHOCARDIOGRAM. A PERICARDIOCENTESIS WAS PERFORMED. THE CASE OUTCOME IS UNKNOWN. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2245975 | DIAMONDTEMP¿ | CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION | OAE | EPIX THERAPEUTICS | EPIX-UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Life Threatening| R |